Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Insulin signaling pathway | R-HSA-74752 | map04910 | cortisone | 222786 | drug-path |
| ErbB signaling pathway | R-HSA-168638 | map04012 | cortisone | 222786 | drug-path |
| Chronic myeloid leukemia | R-HSA-9680350 | map05220 | cortisone | 222786 | drug-path |
| Glioma | Q9NZM4 | map05214 | cortisone | 222786 | drug-path |
| Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | cortisone | 222786 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | nimodipine | 4497 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | nimodipine | 4497 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | nimodipine | 4497 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | nimodipine | 4497 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | nimodipine | 4497 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | salbutamol | 2083 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | salbutamol | 2083 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | salbutamol | 2083 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | salbutamol | 2083 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | salbutamol | 2083 | drug-path |
| Asthma | R-HSA-444620 | map05310 | salbutamol | 2083 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | salbutamol | 2083 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | salbutamol | 2083 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | salbutamol | 2083 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | salbutamol | 2083 | drug-path |